Using these comprehensive approaches, an array of novel pathogenic variants—including single nucleotide variants, InDels (insertions/deletions), and copy number variations—were detected in RB patients [37,38] and the time and number of assays required for detection of RB1 pathogenic variants were reduced. The gene discussed is RB1; the disease is retinoblastoma.